mavorixafor will increase the degree or impact of codeine by impacting hepatic enzyme CYP2D6 metabolism. Contraindicated. Mavorixafor (a robust CYP2D6 inhibitor) is contraindicated with medication which have been remarkably depending on CYP2D6 for clearance. Considering the fact that 2019, th